SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aventus Network

Aventus Network ($AVT) is trending, with community members suggesting it's at a potential bottom and encouraging others to "pump" the coin. Some users are pointing to its availability on Coinbase and Mexc, while others discuss its partnerships and technology.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending as the stock rallies, fueled by a new multi-launch contract and potential upside from government contracts. The community is buzzing about continued accumulation by institutional investors and the possibility of a gamma squeeze, while also debating valuation concerns amid the recent surge.  Enthusiasm remains high for the company's long-term prospects, particularly related to the Neutron launch and potential for space-based laser communication capabilities.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

Fueled by a recently closed $75M investment, POET Technologies is trending as the community speculates on the identity of the institutional investor, with some hoping it's a major player like NVDA. Bullish sentiment is further supported by POET's Optical Interposer platform, touted for its potential to revolutionize AI data centers with increased processing speed and reduced power consumption, positioning the company as a key player in the burgeoning AI connectivity sector. The community is also discussing potential acquisitions and new partnerships.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

ATON is trending due to its unique position as a Nasdaq-listed company focused on building a digital asset treasury on the TON blockchain within Telegram, attracting attention from traders looking for the next low-float runner. Community discussions revolve around its potential for significant gains, drawing comparisons to other high-flying stocks with similar characteristics. The company's strategy and leadership, particularly its ties to the crypto world, are also sparking interest.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending following an announcement of a $500M public offering of common stock, leading to a temporary dip in share price that the community is actively debating.  While some investors express concerns over dilution, others view this offering as a strategic move to fund expansion and accelerate the company's progress toward commercialization.  The community remains focused on the long-term potential of eVTOL technology and Joby's competitive position in the sector.

Galecto, Inc. is a clinical-stage biotechnology company, which engages in developing novel small molecule therapeutics that are designed to target the biological processes that lie at the heart of cancer and fibrotic diseases. The firm is also involved in the development of small molecule inhibitors of galectin-3 and LOXL2. The company was founded by Ulf Jörgen Nilsson, Hakon Leffler, Tariq Sethi, and Hans Thalsgård Schambye in 2011 and is headquartered in Boston, MA.

Galecto Inc

Galecto Inc. is trending due to a significant surge in price and volume, reminiscent of other recent low-float runners. The community is actively discussing potential short squeezes, high borrowing rates, and the stock's limited float, contributing to its volatile price action. Some traders caution about pump-and-dump dynamics, while others anticipate further upward momentum.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

$TMC is trending as the deep-sea mining sector gains traction, with community members discussing potential short squeezes and a possible breakout. Optimism is fueled by anticipation of government partnerships and regulatory approvals, particularly the NOAA decision. Bullish investors are focused on the company's long-term potential in the critical minerals market.

BTQ Technologies Corp. engages in the business of post-quantum encryption. It focuses on applications to the blockchain industry. Its products include PQScale, Keelug, Kenting, Preon, QPoW, and QByte. The company was founded by Nicolas Roussy Newton on March 26, 2021 and is headquartered in Vancouver, Canada.

BTQ Technologies Corp

BTQ Technologies Corp is trending as investors are excited about the company's advancements in post-quantum cryptography, especially after the announcement of key semiconductor experts joining the team. Community discussions highlight BTQ's potential for growth in the quantum security space and its relatively low market cap compared to competitors, with some drawing comparisons to early-stage opportunities in the crypto market.

Fitell Corp. engages in the business of selling gym and fitness equipment. It also offers turnkey solution for personal training studios and commercial gym chains. Its brands include Muscle Motion, Rapid Motion, and FleetX. The company was founded in 2007 and is headquartered in Sydney, Australia.

Fitell Corp - Ordinary Shares - Class A

Fitell Corp

FTEL is trending due to its low float and recent news regarding Solana treasury expansion and Nasdaq extension approval, leading to speculation of a potential breakout; the community is actively discussing squeeze potential and price target of 19.25, with some noting price discrepancies across different platforms; others are considering the stock as a potential play in the fitness equipment sector.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid community discussions about positive data, a potential short squeeze, and speculation around a buyout. Investor confidence seems to be returning, with many highlighting the stock's undervaluation and upcoming catalysts like conference presentations and earnings. Community members are closely watching resistance levels and expressing optimism about the stock's long-term potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Healthcare Realty Trust (HR) Reports Q2 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Healthcare Realty Trust (HR) give a sense of how its business performed in the quarter ended June 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Healthcare Realty Trust (HR) Tops Q2 FFO Estimates

Healthcare Realty Trust (HR) delivered FFO and revenue surprises of +2.50% and -0.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Forecasting The Future: 6 Analyst Projections For Healthcare Realty Trust

Latest Ratings for HR
 DateFirmActionFromTo Feb 2022Credit SuisseInitiates Coverage OnOutperform Jan 2022BMO CapitalDowngradesOutperformMarket Perform Aug 2021Raymond JamesDowngradesStrong BuyMarket...

5 Analysts Assess Healthcare Realty Trust: What You Need To Know

Unveiling 5 Analyst Insights On Healthcare Realty Trust

Clay Northam Wealth Management LLC Sells 950 Shares of Healthcare Realty Trust Incorporated (NYSE:HR)

Clay Northam Wealth Management LLC lowered its holdings in Healthcare Realty Trust Incorporated (NYSE:HR - Free Report) by 3.4% in the fourth quarter, according to its most recent 13F filing with the...

Healthcare Realty Trust Incorporated (NYSE:HR) Receives $17.30 Average Target Price from Brokerages

Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) has received a consensus rating of "Hold" from the ten research firms that are covering the company, MarketBeat Ratings reports...

5 Best Beaten Down Dividend Stocks to Invest in Now

In this article, we discuss 5 best beaten down dividend stocks to invest in. If you want to read our detailed analysis of dividend stocks and their performance in the past, go directly to read 11...

Healthcare Realty Trust Incorporated (NYSE:HR) Stake Increased by Wellington Management Group LLP

Wellington Management Group LLP increased its stake in Healthcare Realty Trust Incorporated (NYSE:HR  Free Report) by 1.3% in the third quarter, according to the company in its most recent...

Handelsinvest Investeringsforvaltning Invests $530,000 in Healthcare Realty Trust Incorporated (NYSE:HR)

Handelsinvest Investeringsforvaltning acquired a new stake in Healthcare Realty Trust Incorporated (NYSE:HR  Free Report) in the fourth quarter, according to its most recent disclosure with...

Healthcare Realty Trust, Inc. engages in providing real estate investment services. It owns, leases, manages, acquires, finances, develops, and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States of America. The company was founded by David R. Emery in 1992 and is headquartered in Nashville, TN.

Healthcare Realty Trust Inc - Ordinary Shares - Class A

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$17.96
Prev Close	$17.74
Open	$17.75
Dividend Yield	7.32%
50-Day Moving Average	$17.29
Beta	0.62
Avg. Volume	4.67M
PE Ratio	-15.38

52-Week High	$18.82
52-Week Low	$14.09
Market Capitalization	$6.24B
EPS (Annual)	-$1.81
Price to Book	1.29
Revenue Per Employee	$2.31M
Enterprise Value/EBITDA	N/A

HR Healthcare Realty Trust, Inc.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HR News